Adenosquamous carcinoma of extrahepatic bile duct: clinicopathologic study of 12 cases.
Adenosquamous carcinoma is a rare histologic subtype of extrahepatic bile duct (EBD) carcinoma and limited information is available on its clinicopathologic characteristics. Twelve cases of adenosquamous carcinoma were collected from 3 institutions and their clinicopathologic characteristics were examined and compared with those of 176 EBD adenocarcinomas. The adenocarcinoma component was more often seen at the surface of the tumor (7 of 12 cases, 58%), while the squamous carcinoma component was slightly more frequent at the advanced edge (7 of 12 cases, 58%). Immunohistochemistry, available in 10 cases, revealed that S100A2 was positive in the squamous carcinoma component in all 10 cases (100%), while it was present in the adenocarcinoma component in only 2 of 10 cases (20%, chi-square test, p=0.001). S100A4 expression did not show any difference between the two components. Patients with adenosquamous carcinomas had worse survival (median survival, 11 months) than those with adenocarcinoma (median survival, 32 months; log-rank test, p=0.003). Patients with predominant squamous cell carcinoma component at the leading edge had worse survival than those without it. In conclusion, patients with adenosquamous carcinoma demonstrated worse survival than those with pure adenocarcinoma. S100A2 immunohistochemical staining may be helpful in detecting the squamous component.
Hong
Seung-Mo
SM
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA. shong28@jhmi.edu
Kim
Mi-Jung
MJ
Jang
Kee-Taek
KT
Yoon
Ghil-Suk
GS
Cho
Hyungjun
H
Frierson
Henry F
HF
Yu
Eunsil
E
Nihon Kyobu Shikkan Gakkai Zasshi. 1994 Feb;32(2):161-7
8164404
JOP. 2005 Mar 10;6(2):162-5
15767732
Biochem Biophys Res Commun. 2004 Oct 1;322(4):1111-22
15336958
J Gastroenterol. 2005 Feb;40(2):192-9
15770404
Ryoikibetsu Shokogun Shirizu. 1996;(9):61-3
8705560
J Surg Oncol. 1980;15(1):29-35
7421268
J Gastroenterol Hepatol. 1993 Nov-Dec;8(6):607-12
8280849
Diagn Cytopathol. 1996 Nov;15(4):322-4
8982588
Cancer Res. 2002 Dec 1;62(23):6823-6
12460893
Neoplasia. 2006 Oct;8(10):843-50
17032501
J Gastroenterol. 2000;35(6):465-71
10864356
Chir Ital. 2004 Mar-Apr;56(2):289-95
15152526
Histol Histopathol. 2002 Jan;17(1):123-30
11813862
Gynecol Oncol. 2003 Dec;91(3):558-62
14675676
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2309-16
9815629
South Med J. 1978 Feb;71(2):216-9
622635
Tumour Biol. 2004 Jan-Apr;25(1-2):31-40
15192310
Ann Thorac Surg. 1987 Nov;44(5):462-6
3675050
Gastrointest Endosc. 2004 Aug;60(2):300-4
15278069
Biochem Cell Biol. 2004 Aug;82(4):508-15
15284904
Pathologica. 2000 Oct;92(5):323-6
11198466
Am J Surg Pathol. 2007 Feb;31(2):199-206
17255764
Methods Mol Biol. 2005;289:209-22
15502186
Br J Cancer. 2004 Oct 18;91(8):1515-24
15467767
J Surg Oncol. 1986 Oct;33(2):140-2
3531727
Int J Mol Med. 2000 Nov;6(5):539-42
11029520
Dis Colon Rectum. 1999 Feb;42(2):258-63
10211505
Cancer. 2003 May 1;97(9):2196-202
12712471
Cancer. 2005 Aug 15;104(4):802-10
15959914